Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by fredgoodwinsonon Apr 09, 2020 11:02am

195 Views

Post# 30893994

Into reverse

In this for the longer term (6 years` to date) - not the first time that expectation hope and then the will to live have been sequentially extinguished by this style of delivery - or lack of it.If you promise an update only every 3 months you deliver it - good or bad.

Mackie and BMO - for me the ‘ house’ firms - started selling yesterday. Doesn`t look as if they`ve stopped yet.

Bullboard Posts

StockTalk | Cannabis Report: New CEO, new dispensaries, new strains